Insider Transactions in Q2 2023 at Y M Abs Therapeutics, Inc. (YMAB)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 08
2023
|
Laura Hamill Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,330
+50.0%
|
-
|
|
Jun 08
2023
|
Ashu Tyagi Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,330
+50.0%
|
-
|
|
Jun 08
2023
|
James Healy Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,330
+7.65%
|
-
|
|
Jun 08
2023
|
David N Gill Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,330
+50.0%
|
-
|
|
Jun 08
2023
|
Gerard Ber Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,330
+50.0%
|
-
|
|
Jun 08
2023
|
Johan Wedell Wedellsborg Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,330
+50.0%
|
-
|
|
May 15
2023
|
Biotech Ap S Wg Director |
BUY
Open market or private purchase
|
Direct |
101,740
+2.32%
|
$915,660
$9.65 P/Share
|
|
May 15
2023
|
Johan Wedell Wedellsborg Director |
BUY
Open market or private purchase
|
Indirect |
101,740
+2.32%
|
$915,660
$9.65 P/Share
|